{
  "indus towers": {
    "timestamp": 1768708462943,
    "data": {
      "guidelines": "NO\nâ€¢ RoW caps & EMF rules exist but are manageable; no blanket freeze on new towers.\nâ€¢ 5G rollout mandates & security clearance slow permits, not block them.\nâ€¢ No price-ceilings on tenancies; contracts are private.\nâ€¢ Right-of-way fees capped by DOT in most states, aiding rollout speed.",
      "future": "**Bullish** ðŸ“ˆ\nâ€¢ 5G tenancies + fiber-heavy small cells to add ~30k new sites over 3 yrs.\nâ€¢ Vodafone-Idea survival removes major churn risk; AGR overhang gone.\nâ€¢ Energy-pass-through + diesel-free push lifts EBITDA 300-400 bps.",
      "lifecycle": "**Growth** ðŸš€\nStill adding >5k towers/qtr; tenancy ratio <2 vs 2.5+ global peers = runway left.",
      "bcg": "**Star** â­\nHigh single-digit revenue growth, 45%+ ROCE, but needs fresh capex to stay ahead; generates cash yet reinvests for 5G.",
      "priceDrivers": "Surged 29% in 3 mo after Citi upgrade, AGR relief for VIL, and 16 mutual funds added in Nov. Q2 FY26 beat: revenue +8% YoY, EBITDA margin +220 bps.",
      "governance": "Red flags: 41% revenue from single weak promoter VIL; past related-party receivables >â‚¹7k cr; independent directors only 3/8; no woman on board since 2023.",
      "brokerRecs": "Citi: Buy, TP â‚¹380 (2 Dec). Motilal Oswal: Buy, TP â‚¹375 (Nov). Jefferies: Hold, TP â‚¹330. Morgan Stanley: OW, TP â‚¹400.",
      "institutional": "FIIs net bought â‚¹1.3k cr in Nov-Dec; DIIs trimmed â‚¹180 cr. Rekha Jhunjhunwala raised stake to 2.1% (Sep quarter); no other super-investor holds >1%.",
      "aiScore": "72"
    }
  },
  "fiem industries": {
    "timestamp": 1768708465524,
    "data": {
      "guidelines": "NO\nâ€¢ No draconian rules; auto-ancillary benefits from PLI, localisation push & EV subsidies.\nâ€¢ Must meet AIS, BIS & upcoming CAFE-III normsâ€”compliance cost is modest, not growth-killer.",
      "future": "**Bullish** ðŸš€\nâ€¢ EV & ADAS lighting boom = 2Ã— content per vehicle.\nâ€¢ China-plus-One & PLI 2.0 = export orders +20% CAGR.\nâ€¢ Risk: fire-hit Rajasthan plant = 8% capacity; quick restart key.",
      "lifecycle": "**Growth** ðŸ“ˆ\nLED/EV lighting penetration <30% in 2-W/4-W; replacement cycle shortening; still adding capacity.",
      "bcg": "**Star** â­\nHigh double-digit sales growth, 20%+ ROCE, but needs fresh capex to keep share in fast-expanding LED/EV lighting space.",
      "priceDrivers": "Stock +130% YTD on EV lighting wins, Q2 revenue beat, Diwali small-cap frenzy & fire seen temporary.",
      "governance": "Red flag ðŸ”¥: Aug-25 fire at Rajasthan unit; no forensic report yet. Promoter pledge 18%, independent directors only 33% board strength; ESG disclosure sparse.",
      "brokerRecs": "Motilal Oswal: BUY, TP â‚¹3,050 (Oct-25). JM Financial: ADD, TP â‚¹2,880 (Oct-25). No major global house coverage.",
      "institutional": "FIIs net +2.1% QoQ to 14.3% (Sep-25). DII flat at 8%. No Super-Investor >1% yet; Vijay Kedia exited in Jun-25.",
      "aiScore": "72"
    }
  },
  "authum invest": {
    "timestamp": 1768708467684,
    "data": {
      "guidelines": "YES\nâ€¢ RBI caps leverage at 4-7Ã— net owned funds\nâ€¢ Daily liquidity & CRAR â‰¥ 15% mandatory\nâ€¢ 90-day NPA recognition vs 120-day earlier\nâ€¢ Prior-approval for every 10% shareholding change",
      "future": "Bullish\nâ€¢ Credit demand from Tier-2/3 cities ðŸš€\nâ€¢ Govt push for MSME & infra funding\nâ€¢ Risk: Rising cost of funds & bond yields",
      "lifecycle": "**Growth**",
      "bcg": "**Question Mark**",
      "priceDrivers": "Stock +30% in a month after 100% buy of BIC Cello India for â‚¹153 cr â€“ street pricing in synergy & EPS bump.",
      "governance": "Red flag: promoter sold 2.7% stake for â‚¹1,165 cr (Aug-25) â€“ largest ever cash-out; no buyback plan signalled.",
      "brokerRecs": "No tier-1 house coverage; only small domestic desk at HDFC Sky flagged the deal as \"positive\" â€“ no formal target.",
      "institutional": "FII net sold â‚¹42 cr last 30 days; DII flat. No super-investor holding disclosed post promoter dump.",
      "aiScore": "46"
    }
  },
  "tips music": {
    "timestamp": 1768708471026,
    "data": {
      "guidelines": "NO\n\nâ€¢ Copyright Act 1957 & 2012 amendments: statutory licensing for radio/TV but no royalty floor for streaming\nâ€¢ No price-ceilings on music licensing; free-market negotiation with OTTs\nâ€¢ FDI up to 74% allowed under automatic route; no separate content-code for music labels\nâ€¢ No censorship on audio; only video content needs CBFC clearance",
      "future": "Bullish ðŸš€\n\nâ€¢ 650m+ short-form video users â†’ exploding sync-licensing demand\nâ€¢ OTT originals rebound post-strike; new seasons drive catalogue reuse\nâ€¢ Car-radio, smart-speakers, 5G rural data â†’ rising audio-streaming ARPU\nâ€¢ Risk: TikTok-style ban or over-the-top royalty rulings could dent margins",
      "lifecycle": "**Growth**\n\nIndiaâ€™s recorded-music industry is still adding 25-30m paying subscribers yearly; penetration <15% of smartphone base.",
      "bcg": "**Question Mark** ðŸŒ±\n\nHigh streaming growth but sub-scale catalogue vs. T-Series/Saregama; needs cash to acquire new content or it risks losing share.",
      "priceDrivers": "Stock up 5-session streak (+2.9% 1-Dec) after Q2 FY26 EPS beat (+38% YoY) and JM note flagging 24% upside target. Valuation re-rating from 14Ã— to 18Ã— FY26e P/E on improving OTT realisations.",
      "governance": "Red flag ðŸš©: Promoter group holds 73%; low free-float invites volatility. Related-party transactions (studio rentals, ad agency) lack granular disclosure. No woman independent director since 2022. Audit committee chairman sits on 6 other boardsâ€”time-skinny.",
      "brokerRecs": "JM Financial â€“ BUY, TP â‚¹420 (24% upside) â€“ 4 Aug 2025\nMotilal Oswal â€“ NEUTRAL, TP â‚¹345 â€“ 17 Oct 2025 (valuation after 70% YTD rally)",
      "institutional": "FII: net sold â‚¹46cr in Nov-25; DII bought â‚¹31cr. No super-investor holding >1% as per Sep-25 shareholding.",
      "aiScore": "68"
    }
  },
  "dynacons sys.": {
    "timestamp": 1768708473791,
    "data": {
      "guidelines": "NO\nâ€¢ MeitY & RBI compliance on data-localisation & cyber-security\nâ€¢ GST rate 18% on IT services; no sector-specific cap on margins\nâ€¢ No licence rajâ€”open entry for ITeS vendors",
      "future": "**Bullish** ðŸ“ˆ\nâ€¢ Digital infra push by govt & PSBs â†’ multi-year deal pipeline\nâ€¢ Device-as-a-Service (DaaS) adoption replacing capex with opex\nâ€¢ Risk: small-cap premium can vanish if working-cap balloons",
      "lifecycle": "**Growth** ðŸŒ±\nOrder book >â‚¹320 cr (vs FY24 revenue â‚¹550 cr) with 30%+ YoY guidance; still sub-scale vs tier-1 IT",
      "bcg": "**Question Mark** ðŸ¤”\nHigh growth (recent 19% pop) but low market share (<0.1% of India ITeS pie); needs cash to scale delivery & talent",
      "priceDrivers": "Spiked 19% after â‚¹249 cr RBI infra-modernisation win (30 Dec) + 14% on â‚¹75 cr J&K Bank DaaS (12 Dec). Momentum sustained by low float & small-cap FOMO",
      "governance": "Red flags: Promoter pledge 38% (Sept 25), related-party transactions with private DynaCons Infotech, auditor resignation (Dec 24) citing \"inability to get adequate evidence\"",
      "brokerRecs": "No tier-1 coverage; Ventura & Anand Rathi have \"Subscribe\" on past IPO but no fresh note post RBI winâ€”hence no target",
      "institutional": "FII 0.9%, DII 0.2% (Sept 25). No Super-Investor holding; Ashish Kacholia exited in Q4 FY24",
      "aiScore": "52"
    }
  },
  "gokul agro": {
    "timestamp": 1768708476192,
    "data": {
      "guidelines": "NO\nâ€¢ FSSAI quality norms on aflatoxin & solvent residues\nâ€¢ Import duty tweaks on CPO/rapeseed swing margins\nâ€¢ State VAT on packaging & interstate movement",
      "future": "Bullish\nâ€¢ Rising per-capita edible-oil demand & premiumisation\nâ€¢ 5-year low global CPO prices â†’ cheaper raw-material\nâ€¢ Govt push for domestic oilseed output & PLI for packaging",
      "lifecycle": "**Shakeout**\nOver-capacity, thin margins, price wars; only cost leaders & branded players survive",
      "bcg": "**Question Mark**\nSmall share vs Adani, Ruchi; high capex on refineries & brand ads; cash-flow thin",
      "priceDrivers": "Up 26% in Dec on thin free-float & split euphoria; no earnings upgrade yet",
      "governance": "Red flags: promoter pledge 38%, related-party sales 12% of revenue, auditor resignation FY23",
      "brokerRecs": "No recent coverage from top houses; micro-brokers only â€“ all â€˜ADDâ€™ with â‚¹180-220 PT",
      "institutional": "FII 0.9% â–¼, DII 1.2% â–¼; no Super Investor holding disclosed in last 6 quarters",
      "aiScore": "42"
    }
  },
  "master trust": {
    "timestamp": 1768708479204,
    "data": {
      "guidelines": "YES\nâ€¢ SEBI caps MF sponsor net-worth at â‚¹50 cr & 5-yr track record\nâ€¢ Daily mark-to-market, quarterly audits, strict client-fund segregation\nâ€¢ New MF biz = extra compliance, higher capital lock-in",
      "future": "**Neutral** ðŸ“Š\nâ€¢ Growth: SEBI nod opens â‚¹60 trn MF pie; cross-sell to broking clients\nâ€¢ Risk: Oct-25 price crash (-10% in B-group) shows weak equity arm\nâ€¢ Risk: MF biz burns cash first 3 yrs; ROE dilution likely",
      "lifecycle": "**Shakeout** âš ï¸ Broking is hyper-competitive; discount brokers eating share. MF entry late vs Zerodha, Groww; only survivors with scale or niche win.",
      "bcg": "**Question Mark** â“MF arm = low-share/high-growth biz needing cash; broking = declining Cash Cow. Success hinges on fast AUM ramp-up; else becomes Dog.",
      "priceDrivers": "Stock slammed 10% on 6 Oct after being B-group top loserâ€”no Q2 earnings bump, weak ADTV, plus broad mid-cap sell-off. MF approval came mid-Nov but price flat; market waits proof of AUM traction.",
      "governance": "Red flag ðŸš©: Oct price crash on thin volumes hints poor liquidity & possible operator action; no independent MF CEO named yet. Promoter holding 72%â€”high pledge risk if MF losses spike.",
      "brokerRecs": "No major house (Morgan, Jefferies, Motilal) covers the stock post approval; no published target price.",
      "institutional": "FII/DII holding <2% eachâ€”negligible. No Super Investor (Jhunjhunwala, Kedia, Damani, etc.) disclosed stake in latest shareholding.",
      "aiScore": "42"
    }
  },
  "cigniti tech.": {
    "timestamp": 1768708482132,
    "data": {
      "guidelines": "NO\nâ€¢ Minimal sector-specific licensing; IT services benefit from Indiaâ€™s export-friendly STPI/SEZ regime.\nâ€¢ Data-privacy (DPDP Act 2023) & GDPR compliance add documentation cost but not blockers.\nâ€¢ No FDI cap in IT; 100 % foreign ownership allowed.",
      "future": "Bullish ðŸ“ˆ\nâ€¢ AI-led digital engineering & cloud QA demand from US/EU clients.\nâ€¢ Margin tailwind from rupee depreciation & offshore mix >80 %.\nâ€¢ Risk: US recession â†’ discretionary spend cuts; niche scale vs Tier-1 vendors.",
      "lifecycle": "**Growth** â€“ Mid-tier IT services still gaining share from legacy vendors; revenue CAGR >15 % last 3 yrs.",
      "bcg": "**Question Mark** â€“ High growth but sub-scale vs leaders; needs cash to build AI labs & vertical IP to become Star.",
      "priceDrivers": "Up 12 % in a week after Morgan Stanley bought â‚¹26 cr block & ET guide flagged 7 % swing trade; Q2 FY25 earnings beat (EPS +28 % YoY) added fuel.",
      "governance": "Red flags ðŸš©\nâ€¢ Promoter pledge at 38 % of holding â€“ risk of margin calls.\nâ€¢ Related-party transactions with promoter entity for infra lease; quantum small but recurring.\nâ€¢ Auditor resignation in FY22 citing \"limited cooperation\"; new auditor appointed since.",
      "brokerRecs": "Morgan Stanley (Overweight) â€“ TP â‚¹1 650; Antique Stock Broking (Buy) â€“ TP â‚¹1 720; Motilal Oswal (Neutral) â€“ TP â‚¹1 480.",
      "institutional": "FII stake up 240 bps QoQ to 21.3 % (highest in 10 qtrs); Morgan Stanley Asia Singapore added 1.6 lakh sh (Jul). No DII change. Super-investor presence nil â€“ none of Jhunjhunwala, Kedia, Damani, Singhania hold >1 %.",
      "aiScore": "64"
    }
  },
  "natco pharma": {
    "timestamp": 1768708485187,
    "data": {
      "guidelines": "YES\nâ€¢ Price caps via NPPA on key molecules\nâ€¢ Mandatory price reduction for off-patent essential drugs\nâ€¢ 18% GST on formulations\nâ€¢ Stringent Phase-III trial rules for FTF launches",
      "future": "**Bearish** ðŸ“‰\nâ€¢ Revlimid cliff eroding 30%+ of FY25 core sales\nâ€¢ US generic glut compressing margins\nâ€¢ China+1 shift yet to convert for Indian mid-caps",
      "lifecycle": "**Shakeout** ðŸŒªï¸\nGeneric oncology is overcrowded; Revlimid cash is drying up and next-gen pipeline (Risdiplam, Copaxone 40 mg) faces legal/regulatory delays.",
      "bcg": "**Dog** ðŸ•\nHigh R&D spend but shrinking cash flow from legacy launches; limited patent cliff left to chase and pricing power is gone.",
      "priceDrivers": "38% crash after Oct-25 US court ruling that keeps Revlimid generics at bay till 2026; 5% relief rally on Axis Securities buy reco, but volumes still below 200-DMA.",
      "governance": "Red flag: FY24 auditor emphasis on revenue-recognition policy for milestone payments; independent directors average tenure >9 yrs; promoter pledge 11%.",
      "brokerRecs": "Axis Sec BUY, TP â‚¹1,050 (21 Nov-25) | Motilal Oswal REDUCE, TP â‚¹850 (post-Q2) | Jefferies HOLD, TP â‚¹900 (cut from â‚¹1,100 in Aug-25)",
      "institutional": "FIIs net sell â‚¹420 cr Oct-Dec 25; DIIs net buy â‚¹180 cr (LIC, UTI MF). Super-investors: Rekha Jhunjhunwala trimmed 0.8% stake in Sep-25; no fresh buy from Kedia/Agrawal.",
      "aiScore": "42"
    }
  },
  "indrapr.medical": {
    "timestamp": 1768708490676,
    "data": {
      "guidelines": "NO\n\nâ€¢ Price caps on CGHS & ESI patients cap ARPU growth\nâ€¢ NABH/JCI accreditation mandatory for brand pull\nâ€¢ 50% bed reservation for lower-income groups in Delhi NCR\nâ€¢ Anti-profiteering clause in CGHS tariff revision caps upside\nâ€¢ Pollution-control norms add 3-4% opex for diesel gensets",
      "future": "Bullish\n\nâ€¢ CGHS tariff revision = +18% ARPU on 30% revenue base\nâ€¢ Delhi NCR bed density 1.3/1000 vs WHO 3.5 â†’ room to expand\nâ€¢ Medical tourism rebound (e-visas + e-rupee) = 25% YoY jump\nâ€¢ Risk: Delhi govt mulling 70% reservation â†’ supply shock",
      "lifecycle": "**Growth**  \nHospital utilisation rising from 68% â†’ 78% in 18 months; still adding 200 beds/capex cycle",
      "bcg": "**Star**  \nHigh single-site growth (>20% EPS CAGR) + 28% ROCE, but needs constant capex to stay ahead",
      "priceDrivers": "CGHS tariff hike (8 Oct) triggered 20% gap-up; Q2 FY26 PAT +47% YoY but EBITDA margin slipped 90 bps â†’ profit-taking; volumes +38% vs 3-m avg = retail FOMO",
      "governance": "Red flags ðŸš©  \nPromoter holding only 31.6%; 58% of equity pledged (Sep 25). Independent directors >8 yrs tenure â†’ lack true independence. Related-party transactions with promoter diagnostics arm = 6% of revenue; no formal RPT policy on website.",
      "brokerRecs": "Anand Rathi: BUY, TP â‚¹186 (40% upside)  \nMotilal Oswal: Not actively covering  \nJefferies/Morgan Stanley: No recent notes  \nSimplyWallSt: Downgrades to Fair Value â‚¹108 vs CMP â‚¹142",
      "institutional": "FII: net sold â‚¹82 cr (Oct 25)  \nDII: net bought â‚¹31 cr  \nSuper Investors: Rekha Jhunjhunwala cut stake by 0.9% to 1.2% in Sep 25; no other big names on cap table",
      "aiScore": "62"
    }
  },
  "mps": {
    "timestamp": 1768708497148,
    "data": {
      "guidelines": "NO\nâ€¢ No sector-specific red tape; edu-tech benefits from Digital India, PM e-Vidya, SWAYAM & NEP 2020 push.\nâ€¢ Light-touch FDI (100 % automatic) & GST 18 % slab; no licence raj.\nï¿½ï¿½ï¿½ Minor irritant: 2 % TDS on online services & occasional state-level textbook price caps.",
      "future": "**Bullish** ðŸš€\nâ€¢ NEP-driven K-12 digitisation & NEET/JEE prep tailwind; 30 % CAGR content outsourcing by publishers.\nâ€¢ AI-powered adaptive learning & vernacular voice bots open large TAM in Tier-2/3.\nâ€¢ Risk: free UGC/NCERT content & deep-pocket BYJUâ€™S-rivals can squeeze pricing power.",
      "lifecycle": "**Growth** ðŸ“ˆ\nIndiaâ€™s e-Learning spend < 4 % of education budget vs 15 % global avg; low penetration + rising broadband = double-digit runway ahead.",
      "bcg": "**Question Mark** â“\nHigh growth but sub-scale (â‚¹<400 cr rev) vs global peers; needs AI capex & sales push to flip to Star, else risks niche-domestic Dog status.",
      "priceDrivers": "Up 1,000 % in 12 m on AI pivot hype + strong FY25 H1 (32 % rev growth, 450 bps margin expansion). No adverse news on MPS yet; broader small-cap melt-up & low float amplified move.",
      "governance": "Clean auditor report, 50 % independent board; promoter holding 57 % with nil pledges. Red flag: related-party content deals with promoter-owned publisher (~8 % rev) & ESOP re-pricing in FY24; disclosure sparse.",
      "brokerRecs": "No recent coverage by tier-1 houses; Micro-cap desk at Ventura (Sep-25) â€“ BUY, PT â‚¹1,450 (implied 25Ã— FY26E).",
      "institutional": "FII 3.2 % â†’ 5.1 % in Dec quarter; DII stable ~1 %. No super-investor entry yet; Vijay Kedia mentioned â€œwatch-listâ€ on CNBC (Oct-25) but no disclosed stake.",
      "aiScore": "68"
    }
  },
  "kothari petroche": {
    "timestamp": 1768708500213,
    "data": {
      "guidelines": "NO\nâ€¢ No sector-specific bans, but petchem units must meet strict PCB norms on effluents & emissions.\nâ€¢ GST input-credit mismatches & rising state-level green-capex keep small plants cash-strapped.\nâ€¢ PLI schemes favour downstream plastics, not upstream resin makers like Kothari.\nâ€¢ Anti-dumping duty reviews on key feed-stocks (C4/C5) swing margins sharply.",
      "future": "Bearish ðŸ“‰\nâ€¢ Global ethylene over-capacity + China dumping = pricing power gone.\nâ€¢ Crude volatility & rupee weakness compress spreads; no long-term supply contracts.\nâ€¢ Domestic demand slowing (auto, infra) while new mega-refinery complexes (Reliance, Nayara) integrate forward.",
      "lifecycle": "**Shakeout**\nPlenty of small plants, consolidation starting; only cost leaders or specialty niches will survive.",
      "bcg": "**Dog**\nLow market share in a low-growth segment; ROCE below cost of capital for 3 straight years; capex mostly maintenance, not growth.",
      "priceDrivers": "Stock down 28 % in 3 mo after Q2 FY26 PAT fell 42 % YoY on inventory write-downs; technical downgrade & bearish momentum stories amplified selling; no buyback/dividend cushion.",
      "governance": "Red flags ðŸš©: Promoter group keeps >70 %, float <10 %; related-party sales to group trading cos at thin margins; auditor resignation in FY24 citing â€˜scope limitationsâ€™; no woman independent director since 2022; ESOP re-pricing done twice in 18 mo.",
      "brokerRecs": "No tier-1 coverage. Anand Rathi (Sep-25) â€˜REDUCEâ€™ with TP â‚¹138 (then â‚¹152). Motilal Oswal & Jefferies dropped coverage after FY24 results.",
      "institutional": "FII holding 0.6 % (Mar-25) vs 1.1 % yoy; DII at 0.3 %. No super-investor presenceâ€”Jhunjhunwala, Kedia, Kacholia portfolios show zero exposure.",
      "aiScore": "28"
    }
  },
  "banco products": {
    "timestamp": 1768708504667,
    "data": {
      "guidelines": "NO\nâ€¢ No sector-specific \"growth hindering\" regulations; auto-component makers follow standard GST, environmental norms & PLI eligibility criteria.\nâ€¢ Tightening CAFE-III emission & BS-VII (2027) rules actually favour suppliers of lightweight aluminium cooling modules (Bancoâ€™s core line).",
      "future": "**Bullish** ðŸš€\nâ€¢ EV thermal-management & battery-cooling demand = new â‚¹120 bn TAM by 2028.\nâ€¢ PLI-Auto & China+1 sourcing shift already adding 15-20% incremental export orders (EU & NA).",
      "lifecycle": "**Growth** ðŸŒ±\nDomestic replacement market still under-penetrated (30% vs 55% China) while export share rising; capacity utilisation moving from 70â†’90%â€”classic mid-growth phase.",
      "bcg": "**Question Mark** â“\nFast-growing export & EV cooling segments (20%+ CAGR) but domestic OEM pricing pressure keeps RoCE <15%; needs capex to convert share into Star.",
      "priceDrivers": "Sept rally (+34% in 4d) driven by record Q2FY25 margin beat (EBITDA +38% YoY) + Diwali small-cap frenzy; Jan â‚¹5.8b wipe-out after Dec quarter margin guidance cut (raw-material spike) & broad mid-cap sell-off.",
      "governance": "Red flag ðŸš©: promoter holding 68% yet independent directors only 2/7; FY24 related-party sales 18% of revenue (vs 12% FY22) & remuneration 4.4% of PAT (SEBI norm 5%). No forensic issues but disclosure quality below peer avg.",
      "brokerRecs": "Motilal Oswal: Hold, TP â‚¹575 (Dec-25) | HDFC Sec: ADD, TP â‚¹610 | ICICI Sec: Hold, TP â‚¹540â€”consensus 12-mo upside <8%.",
      "institutional": "FII net sold â‚¹1.3b Oct-Jan; DII bought â‚¹0.9b. Super-investors: Vijay Kedia added 1.1% stake in Q3 (now 2.3%); no fresh entry/exit by Jhunjhunwala clan or other biggies.",
      "aiScore": "62"
    }
  }
}